199 related articles for article (PubMed ID: 2423305)
1. The role of tumour markers and lymphography in determining clinical stage of non-seminomatous testis tumours.
Zvara V; Hornák M; Breza J; Krídl J
Czech Med; 1986; 9(1):9-14. PubMed ID: 2423305
[TBL] [Abstract][Full Text] [Related]
2. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
Otto T; Goepel M; Seeber S; Rübben H
Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
[TBL] [Abstract][Full Text] [Related]
3. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
[No Abstract] [Full Text] [Related]
4. [Nonbulky nonseminomas: N-staging value of image-producing study procedures with reference to possible surveillance management].
Tradowsky M; Bähren W; Egghart G; Altwein JE
Urologe A; 1986 May; 25(3):160-3. PubMed ID: 3016966
[TBL] [Abstract][Full Text] [Related]
5. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of tumor proteins and lymphography with findings from lymphadenectomy in nonseminomatous tumors of the testis].
Hornák M; Breza J; Krídl J; Zvara V
Rozhl Chir; 1984 Apr; 63(4):235-40. PubMed ID: 6205455
[No Abstract] [Full Text] [Related]
7. Correlation of serum tumor markers and lymphangiography with degrees of nodal involvement in surgical stage II testis cancer.
Vugrin D; Whitmore WF; Nisselbaum J; Watson RC
J Urol; 1982 Apr; 127(4):683-4. PubMed ID: 6175770
[TBL] [Abstract][Full Text] [Related]
8. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
9. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
10. Tumour markers in testicular tumours.
Chisholm GD
Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
[No Abstract] [Full Text] [Related]
11. [Lymphography in malignant testicular tumors].
Fischer U; Gregl A; Bartels H; Blech M; Zinn H
Z Lymphol; 1987 Jul; 11(1):8-13. PubMed ID: 3630344
[TBL] [Abstract][Full Text] [Related]
12. [Is lymphadenectomy in stage I of non-seminomatous testicular cancer still justified?].
Höltl W; Kosak D; Pont J; Hruby W
Wien Klin Wochenschr; 1987 Jan; 99(2):60-3. PubMed ID: 3564488
[TBL] [Abstract][Full Text] [Related]
13. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in nonseminomatous testicular cancer.
Javadpour N
Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
[No Abstract] [Full Text] [Related]
15. [Comparison of clinical and histopathologic diagnosis for early stages of advanced nonseminomatous germ cell testicular tumors].
Sosnowski M; Płuzańska A; Chmielowski M; Dowgier-Witczak I; Jeromir L
Pol Merkur Lekarski; 1997 Apr; 2(10):273-6. PubMed ID: 9377665
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
[TBL] [Abstract][Full Text] [Related]
18. [Staging of testicular cancer by ultrasound and tumor markers with special respect to stage I and IIA].
Behrendt H; Heckemann R; Meyer-Schwickerath M; Hartung R
Urol Int; 1983; 38(5):279-84. PubMed ID: 6195792
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of retroperitoneal lymph node metastases of non-seminomatous germ cell tumours of the testis.
Hogeboom WR; Hoekstra HJ; Mooyaart EL; Sleijfer DT; Schraffordt Koops H
Eur J Surg Oncol; 1993 Oct; 19(5):429-37. PubMed ID: 8405478
[TBL] [Abstract][Full Text] [Related]
20. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
